Lioton

Heparin Sodium, the active ingredient in Lioton, is an anticoagulant presented as a topical formulation for local use. It helps prevent clot formation in superficial vascular conditions and is used in patients requiring localized antithrombotic therapy.

GNH USA supplies Lioton as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lioton, a topical heparin sodium preparation, is employed in superficial vascular and wound‑care settings where localized antithrombotic activity is needed.

- Superficial thrombophlebitis: reduces clot formation and inflammation in affected veins. - Skin grafts and flaps: improves microcirculation and prevents thrombosis of the graft. - Burns and wound care: limits local clotting and supports healing.

Lioton may cause a range of local and systemic adverse reactions.

Common Side Effects: - Local erythema: mild redness at the application site. - Skin irritation: itching or mild rash. - Bruising: minor discoloration of the skin. - Dryness: skin becomes dry or flaky.

Serious or Rare Side Effects: - Systemic anticoagulation: unexpected bleeding beyond the application area. - Allergic reaction: hives, swelling, or anaphylaxis. - Heparin‑induced thrombocytopenia: rare drop in platelet count that can lead to thrombosis. - Severe skin necrosis: localized tissue death at the site of application.

Before using Lioton, consider the following safety measures.

- Assess bleeding risk: avoid use on patients with active hemorrhage. - Avoid concurrent systemic anticoagulants: may increase bleeding. - Do not apply to open wounds without physician guidance. - Monitor for signs of thrombocytopenia: check platelet counts if prolonged use. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Lioton can interact with other medications that affect coagulation.

Major Interactions (Avoid): - Concurrent use with systemic heparin: additive anticoagulant effect. - Combination with warfarin or direct oral anticoagulants: increased bleeding risk.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may potentiate bleeding. - Antiplatelet agents (aspirin, clopidogrel): monitor for bruising. - Topical corticosteroids: may alter skin absorption of heparin.